134 related articles for article (PubMed ID: 27527891)
1. Miz1, a Novel Target of ING4, Can Drive Prostate Luminal Epithelial Cell Differentiation.
Berger PL; Winn ME; Miranti CK
Prostate; 2017 Jan; 77(1):49-59. PubMed ID: 27527891
[TBL] [Abstract][Full Text] [Related]
2. Transient induction of ING4 by Myc drives prostate epithelial cell differentiation and its disruption drives prostate tumorigenesis.
Berger PL; Frank SB; Schulz VV; Nollet EA; Edick MJ; Holly B; Chang TT; Hostetter G; Kim S; Miranti CK
Cancer Res; 2014 Jun; 74(12):3357-68. PubMed ID: 24762396
[TBL] [Abstract][Full Text] [Related]
3. Aberrant CREB1 activation in prostate cancer disrupts normal prostate luminal cell differentiation.
Watson MJ; Berger PL; Banerjee K; Frank SB; Tang L; Ganguly SS; Hostetter G; Winn M; Miranti CK
Oncogene; 2021 May; 40(18):3260-3272. PubMed ID: 33846571
[TBL] [Abstract][Full Text] [Related]
4. Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.
Shatnawi A; Malkaram SA; Fandy T; Tsouko E
Mol Cell Biochem; 2020 Jan; 464(1-2):153-167. PubMed ID: 31773467
[TBL] [Abstract][Full Text] [Related]
5. N-methyl-N-nitro-N-nitrosoguanidine-mediated ING4 downregulation contributed to the angiogenesis of transformed human gastric epithelial cells.
Chen Y; Fu R; Xu M; Huang Y; Sun G; Xu L
Life Sci; 2018 Apr; 199():179-187. PubMed ID: 29496496
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1.
Shen JC; Unoki M; Ythier D; Duperray A; Varticovski L; Kumamoto K; Pedeux R; Harris CC
Cancer Res; 2007 Mar; 67(6):2552-8. PubMed ID: 17363573
[TBL] [Abstract][Full Text] [Related]
7. A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis.
Kim S; Welm AL; Bishop JM
Cancer Res; 2010 Jun; 70(12):5155-62. PubMed ID: 20501848
[TBL] [Abstract][Full Text] [Related]
8. ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth.
Moreno A; Soleto I; García-Sanz P; Moreno-Bueno G; Palmero I
Oncogene; 2014 Apr; 33(15):1945-53. PubMed ID: 23604125
[TBL] [Abstract][Full Text] [Related]
9. ING4 inhibits the translation of proto-oncogene MYC by interacting with AUF1.
Lu M; Pan C; Zhang L; Ding C; Chen F; Wang Q; Wang K; Zhang X
FEBS Lett; 2013 Jun; 587(11):1597-604. PubMed ID: 23603392
[TBL] [Abstract][Full Text] [Related]
10. Human prostate luminal cell differentiation requires NOTCH3 induction by p38-MAPK and MYC.
Frank SB; Berger PL; Ljungman M; Miranti CK
J Cell Sci; 2017 Jun; 130(11):1952-1964. PubMed ID: 28446540
[TBL] [Abstract][Full Text] [Related]
11. Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells.
Xie Y; Lv H; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2011 Dec; 26(6):681-95. PubMed ID: 21988227
[TBL] [Abstract][Full Text] [Related]
12. Role of ING4 in human melanoma cell migration, invasion and patient survival.
Li J; Martinka M; Li G
Carcinogenesis; 2008 Jul; 29(7):1373-9. PubMed ID: 18375955
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle regulator ING4 is a suppressor of melanoma angiogenesis that is regulated by the metastasis suppressor BRMS1.
Li J; Li G
Cancer Res; 2010 Dec; 70(24):10445-53. PubMed ID: 21056991
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated ING4 expression suppresses pancreatic carcinoma cell growth via induction of cell-cycle alteration, apoptosis, and inhibition of tumor angiogenesis.
Xie YF; Sheng W; Xiang J; Zhang H; Ye Z; Yang J
Cancer Biother Radiopharm; 2009 Apr; 24(2):261-9. PubMed ID: 19409049
[TBL] [Abstract][Full Text] [Related]
15. ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.
Shatnawi A; Ayoub NM; Alkhalifa AE
Clin Breast Cancer; 2021 Aug; 21(4):e319-e331. PubMed ID: 33334698
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14.
Cai L; Li X; Zheng S; Wang Y; Wang Y; Li H; Yang J; Sun J
Melanoma Res; 2009 Feb; 19(1):1-7. PubMed ID: 19430401
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated p53 and ING4 gene co-transfer elicits synergistic antitumor effects through enhancement of p53 acetylation in breast cancer.
Wu J; Zhu Y; Xu C; Xu H; Zhou X; Yang J; Xie Y; Tao M
Oncol Rep; 2016 Jan; 35(1):243-52. PubMed ID: 26530780
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
19. Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.
Li XH; Kikuchi K; Zheng Y; Noguchi A; Takahashi H; Nishida T; Masuda S; Yang XH; Takano Y
Oral Oncol; 2011 Mar; 47(3):217-23. PubMed ID: 21310648
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity.
Mathema VB; Koh YS
Tumour Biol; 2012 Feb; 33(1):1-7. PubMed ID: 21971889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
